isphere_biz_fin on Nostr: ** BridgeBio has received US approval for a new heart drug, aiming to compete with ...

**
BridgeBio has received US approval for a new heart drug, aiming to compete with Pfizer's existing treatments. The company's innovative medication is designed to address cardiovascular conditions, offering patients an alternative option.

**

Source: https://www.bloomberg.com/news/articles/2024-11-23/bridgebio-gets-us-approval-for-heart-drug-to-compete-with-pfizer